JPRN-UMIN000005936招募中2 期
Phase II study of allogeneic hematopoietic stem cell transplantation using a preparative regimens consisting of iv Bu + Flu + L-PAM for patients with juvenile myelomonocytic leukemia (JMML) - JMML-11
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)0 个研究点目标入组 43 人开始时间: 2011年7月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 43
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1years-old 至 14years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Diagnosis of Noonan syndrome, disorders with germline RAS mutations and ALPS-like diseases with somatic RAS mutations. Intracranial hemorrhage. Heart failure requiring treatment. Chronic renal failure. Active uncontrolled infections. Uncontrolled diabetes mellitus. Liver cirrhosis. Psychiatric problems.
研究者
相似试验
已完成
2 期
Phase II study of allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies using once daily intravenous busulfan and fludarabine as conditioning regimeacute myeloid leukemia(AML) myelodysplastic syndrome(MDS) chronic myelogenous leukemia(CML)JPRN-UMIN000009766Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital75
已完成
2 期
A phase II study of allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies using intravenous busulfan and cyclophosphamide as conditioning regimen.CML(chronic myelogenous leukemia) AML(acute myeloid leukemia) MDS(myelodysplastic syndrome)JPRN-UMIN000003648Kanto Study Group for Cell Therapy Nagoya Blood and Marrow Transplantation (NBMT) Group40
招募中
2 期
AML-SCT15acute myeloid leukemia (AML)JPRN-jRCTs051180190YABE Hiromasa66
招募中
2 期
Phase II study of allogeneic hematopoietic cell transplantation for children with acute myeloid leukemia in first and second complete remission using fludarabine, cytarabine, melphalan and low-dose total body irradiation as a conditioning regimen (AML-SCT15).acute myeloid leukemia (AML)JPRN-UMIN000027821Japan Children's Cancer Group (JCCG)66
招募中
不适用
Clinical Phase II Study of hematopoietic stem ctell transplantation for ataxia telangiectasia and related diseasesataxia telangiectasia DNA damage response disorderJPRN-UMIN000019532Graduate Schoool, Dept. of Community Pediatrics, Perinatal and Maternal Medicine, Tokyo Medical and Dental University5